Peter Hillemans

17PUBLICATIONS
170CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMultiphysics flows (incl. multiphase and reacting flows)Nanotoxicology, health and safetyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 26, 2025
Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical Cancer-An Expert Survey.

Anke Smits, Janneke T Wolswinkel, Mieke L G Ten Eikelder

|Feb 01, 2025
Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer.

Theresa Beckhaus, Linda Kachuri, Taishi Nakase

|Jul 14, 2023
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

Gisella Figlioli, Amandine Billaud, Qin Wang

|Sep 21, 2022
A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial.

Peter Hillemanns, Agnieszka Denecke, Linn Woelber

|Jun 10, 2022
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.

Frederique J Vink, Chris J L M Meijer, Albertus T Hesselink

|Jun 06, 2022
Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.

Fei Chen, Zoltán Novák, Christian Dannecker

Pageof 3

Frequent Collaborators

4 joint publications

Thilo Dörk

3 joint publications

Rüdiger Klapdor

3 joint publications

Peter A Fasching

3 joint publications

Mario Poljak